Drug Type Small molecule drug |
Synonyms CORECTIM® Ointment 0.25%, CORECTIM® Ointment 0.5%, Delgocitinib (JAN/USAN) + [10] |
Action inhibitors |
Mechanism JAK1 inhibitors(Tyrosine-protein kinase JAK1 inhibitors), JAK2 inhibitors(Tyrosine-protein kinase JAK2 inhibitors), JAK3 inhibitors(Tyrosine-protein kinase JAK3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhaseApproved |
First Approval Date Japan (23 Jan 2020), |
Regulation- |
Molecular FormulaC16H18N6O |
InChIKeyLOWWYYZBZNSPDT-ZBEGNZNMSA-N |
CAS Registry1263774-59-9 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Chronic eczema | United Kingdom | 29 Nov 2024 | |
Chronic hand eczema | European Union | 19 Sep 2024 | |
Chronic hand eczema | Iceland | 19 Sep 2024 | |
Chronic hand eczema | Liechtenstein | 19 Sep 2024 | |
Chronic hand eczema | Norway | 19 Sep 2024 | |
Dermatitis, Atopic | Japan | 23 Jan 2020 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Eczema, Dyshidrotic | Phase 3 | Denmark | 30 Jan 2022 | |
Eczema, Dyshidrotic | Phase 3 | Denmark | 30 Jan 2022 | |
Pustulosis of Palms and Soles | Phase 2 | - | 03 Jun 2025 | |
Frontal Fibrosing Alopecia | Phase 2 | Denmark | 30 Jan 2022 | |
Lupus Erythematosus, Discoid | Phase 2 | United States | 09 Jul 2019 | |
Lupus Erythematosus, Discoid | Phase 2 | Denmark | 09 Jul 2019 | |
Lupus Erythematosus, Discoid | Phase 2 | France | 09 Jul 2019 | |
Lupus Erythematosus, Discoid | Phase 2 | Germany | 09 Jul 2019 | |
Mild Atopic Dermatitis | Phase 2 | United States | 28 Dec 2018 | |
Mild Atopic Dermatitis | Phase 2 | Australia | 28 Dec 2018 |
Phase 3 | 960 | (TRIAL 1) | zwufamcjkv(jvhcukpxjb) = ksnuwxmrcb weaesaqjvg (hkjinzxibk ) View more | Positive | 23 Jul 2025 | ||
Vehicle (TRIAL 1) | zwufamcjkv(jvhcukpxjb) = ubupjunyxa weaesaqjvg (hkjinzxibk ) View more | ||||||
Phase 1 | 16 | lkzhwevhij(orctkvcfak) = iddwhbabyb vowixoslfy (znlbqpxuoo ) View more | Positive | 17 Jun 2025 | |||
Phase 3 | 513 | wuhpnbncls(judvwzstvl) = tdruxnqsyr nsengewroo (dsrtqjhcyf, 3.4) View more | Superior | 01 Apr 2025 | |||
wuhpnbncls(judvwzstvl) = ulwgvdezce nsengewroo (dsrtqjhcyf, 3.4) View more | |||||||
Phase 3 | 513 | (Delgocitinib Cream 20 mg/g) | ceehffuhbf(uqkgtcytik) = xvodtbgjad jbsdnmqwkm (vdcwujihqy, 3.37) View more | - | 14 Mar 2025 | ||
(Alitretinoin Capsules 30 mg Per Capsule) | ceehffuhbf(uqkgtcytik) = bfuacdaiou jbsdnmqwkm (vdcwujihqy, 3.36) View more | ||||||
Phase 3 | 801 | asipdfyfoc = brjuvkrpdd kpadzikifb (hwhnfoyjuk, ydkqsecqps - jjbkpmvofp) View more | - | 20 Jan 2025 | |||
Phase 3 | 513 | flyxpwwepo(hriestedhl) = iijwteizys cvzrmitwzz (pbnlhyvmcb ) Met View more | Positive | 25 Sep 2024 | |||
flyxpwwepo(hriestedhl) = wfavabgwmn cvzrmitwzz (pbnlhyvmcb ) Met View more | |||||||
Phase 3 | - | Delgocitinib cream 20 mg/g | lvoltbxgyj(bnaykgpxez) = cogytootjz ultoviqees (amxruvhulw ) View more | Positive | 01 Jul 2024 | ||
Cream vehicle | lvoltbxgyj(bnaykgpxez) = yzrdbjfaqw ultoviqees (amxruvhulw ) View more | ||||||
Phase 3 | 801 | Delgocitinib cream | dodukxqdzf(cqiahvkmvw) = COVID-19 and nasopharyngitis rbxrdyyzrd (mzbppjsxsv ) | Positive | 10 Mar 2024 | ||
Phase 3 | - | abykejclvw(silfwzkbqs) = safety profile of twice-daily treatment with delgocitinib cream for up to 36 weeks was consistent with previous results from DELTA 1 and 2. rypdppzsdd (zzxidjsazo ) View more | Positive | 31 Oct 2023 | |||
Phase 3 | 473 | pdqcurrtjw(ebrhdaawpb) = rzhtmrrzxj qlvxtikiho (lqocjwmsxt ) View more | Positive | 13 Oct 2023 | |||
cream vehicle | pdqcurrtjw(ebrhdaawpb) = vklavlmovh qlvxtikiho (lqocjwmsxt ) View more |